MAR |Interim Report, January – September 2019

Acarix finalized a rights issue to finance further market expansion
In September we announced a rights issue in order to be able to further develop our
product offering and to intensify our international investments. During this period, I had
the opportunity to present Acarix at a large number of events, creating interest and
increased awareness of our company and unique CADScor®System.


Acarix Interim report Jan-Sep 2019

Acarix Delårsrapport jan-sep 2019


About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.